A Challenging Case of Advanced Cardiac Sarcoidosis Refractory to Infliximab Therapy

Clinical Case Reports 2026 Open access

Read full text
Authors: Manal Adel, Mansimran Singh Dulay, Kshama Wechalekar, Vasileios Kouranos, Rakesh D. Sharma
DOI: 10.1002/ccr3.73227
Cited by: 1
References: 8

Abstract

Cardiac sarcoidosis can be life-threatening, and lack of response to immunosuppressive therapy remains a significant challenge in active disease. We present a case of refractory cardiac sarcoidosis despite third-line immunosuppression (infliximab). Ongoing multimodality assessment is essential for managing refractory cardiac sarcoidosis.

Fields of Study & Subjects

Sarcoidosis and Beryllium Toxicity Research Vasculitis and related conditions Eosinophilic Disorders and Syndromes

Publication details

Journal / source
Clinical Case Reports
Publisher
Wiley
Volume
14
Issue
8
Pages
e73227–e73227
Publication date
1 August 2026
Language
EN